PRAC meeting highlights 10-12 May 2023
10/05/2023
Medicines for human use
Pharmacovigilance risk assessment committee (PRAC)
The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) is responsible for assessing and monitoring safety issues for human medicines.
The current PRAC highlights from the May 2023 meeting describes the start of a review into medicines containing hydroxyprogesterone following concerns about the safety and effectiveness of these medicines.